State Street’s Rapid Micro Biosystems RPID Stock Holding History

State Street’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Buy	93,874 +2,400	+3%	+$8.79K	﹤0.01%	3867
2025 Q4	$265K	Hold	91,474	–	–	﹤0.01%	3831
2025 Q3	$306K	Buy	91,474 +31,600	+53%	+$100K	﹤0.01%	3778
2025 Q2	$207K	Hold	59,874	–	–	﹤0.01%	3823
2025 Q1	$158K	Buy	59,874 +33,800	+130%	+$77.1K	﹤0.01%	3878
2024 Q4	$23.5K	Hold	26,074	–	–	﹤0.01%	4221
2024 Q3	$23.2K	Hold	26,074	–	–	﹤0.01%	4212
2024 Q2	$17.2K	Hold	26,074	–	–	﹤0.01%	4286
2024 Q1	$25.3K	Hold	26,074	–	–	﹤0.01%	4266
2023 Q4	$19.3K	Hold	26,074	–	–	﹤0.01%	4348
2023 Q3	$28.2K	Hold	26,074	–	–	﹤0.01%	4395
2023 Q2	$26.1K	Hold	26,074	–	–	﹤0.01%	4555
2023 Q1	$34.2K	Hold	26,074	–	–	﹤0.01%	4601
2022 Q4	$29.5K	Hold	26,074	–	–	﹤0.01%	4672
2022 Q3	$84K	Hold	26,074	–	–	﹤0.01%	4523
2022 Q2	$112K	Sell	26,074 -395,319	-94%	-$1.84M	﹤0.01%	4476
2022 Q1	$2.86M	Buy	421,393 +64,462	+18%	+$475K	﹤0.01%	3430
2021 Q4	$3.8M	Buy	356,931 +265,644	+291%	+$4.15M	﹤0.01%	3366
2021 Q3	$1.69M	Buy	+91,287	New	+$1.89M	﹤0.01%	3654

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

EFA

Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street's RPID Position: Q1 2026 in Review

State Street increased its Rapid Micro Biosystems (RPID) stake by 2.6% in Q1 2026, buying an estimated $8.79K and bringing the position to 93,874 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #3867.

State Street first reported a position in RPID in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.8M in Q4 2021. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

State Street held 93,874 shares of Rapid Micro Biosystems worth $213K as of Q1 2026.
State Street bought 2,400 Rapid Micro Biosystems shares in Q1 2026, an estimated $8.79K.
Rapid Micro Biosystems made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3867 holding.
State Street first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 19 quarters since.
State Street's Rapid Micro Biosystems position peaked at $3.8M in Q4 2021.
46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.